Cargando…

Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study

(1) Background: The role of antihypertensives in Alzheimer’s Disease (AD) prevention is controversial. This case-control study aims to assess whether antihypertensive medication has a protective role by studying its association with amyloid and tau abnormal levels. Furthermore, it suggests a holisti...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Lluch, Gemma, Peña-Bautista, Carmen, Royo, Lucrecia Moreno, Baquero, Miguel, Cañada-Martínez, Antonio José, Cháfer-Pericás, Consuelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059654/ https://www.ncbi.nlm.nih.gov/pubmed/36986785 http://dx.doi.org/10.3390/pharmaceutics15030924

Ejemplares similares

Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer’s Disease
por: Peña-Bautista, Carmen, et al.
Publicado: (2020)

Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages
por: Peña-Bautista, Carmen, et al.
Publicado: (2021)

Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer’s Disease and Frontotemporal Dementia
por: Álvarez-Sánchez, Lourdes, et al.
Publicado: (2023)

Assessment of Lipid Peroxidation in Alzheimer’s Disease Differential Diagnosis and Prognosis
por: Ferré-González, Laura, et al.
Publicado: (2022)

Lipids as Early and Minimally Invasive Biomarkers for Alzheimer’s Disease
por: Casas-Fernández, Esther, et al.
Publicado: (2022)

CRIDECO Anticholinergic Load Scale: An Updated Anticholinergic Burden Scale. Comparison with the ACB Scale in Spanish Individuals with Subjective Memory Complaints
por: Ramos, Hernán, et al.
Publicado: (2022)

Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases
por: Mayo, Sonia, et al.
Publicado: (2021)

Oxidative Damage of DNA as Early Marker of Alzheimer’s Disease
por: Peña-Bautista, Carmen, et al.
Publicado: (2019)

Plasma microRNAs as potential biomarkers in early Alzheimer disease expression
por: Peña-Bautista, Carmen, et al.
Publicado: (2022)

Annual stability of the plasma Aß40/42 ratio and associated factors
por: Nakamura, Takumi, et al.
Publicado: (2023)

Plasma Lipidomics Approach in Early and Specific Alzheimer’s Disease Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2022)

Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis
por: Peña-Bautista, Carmen, et al.
Publicado: (2023)

Early neurotransmission impairment in non-invasive Alzheimer Disease detection
por: Peña-Bautista, Carmen, et al.
Publicado: (2020)

Assessment of Screening Approach in Early and Differential Alzheimer’s Disease Diagnosis
por: Ferré-González, Laura, et al.
Publicado: (2021)

Discordant Amyloid Status Diagnosis in Alzheimer’s Disease
por: García-Vallés, Lorena, et al.
Publicado: (2022)

Corrigendum: Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aß(1−42), and Tau Proteins in Elderly Patients With Mild Cognitive Impairment
por: Duron, Emmanuelle, et al.
Publicado: (2019)

Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2021)

Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer’s Disease Differential Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2020)

Lipid Peroxidation in Neurodegeneration
por: Cháfer-Pericás, Consuelo
Publicado: (2021)

Early Alzheimer’s Disease Screening Approach Using Plasma Biomarkers
por: Álvarez-Sánchez, Lourdes, et al.
Publicado: (2023)

Aß40 displays amyloidogenic properties in the non-transgenic mouse brain but does not exacerbate Aß42 toxicity in Drosophila
por: De Mena, Lorena, et al.
Publicado: (2020)

The Learned Ass
Publicado: (1896)

Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus
por: Patel, Sunil, et al.
Publicado: (2012)

Tau- but not Aß -pathology enhances NMDAR-dependent depotentiation in AD-mouse models
por: Faldini, Enrico, et al.
Publicado: (2019)

Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology
por: Jiwaji, Zoeb, et al.
Publicado: (2022)

A Structure-Toxicity Study of Aß(42) Reveals a New Anti-Parallel Aggregation Pathway
por: Vignaud, Hélène, et al.
Publicado: (2013)

And Baalam’s Ass Spake
Publicado: (1901)

The nonlinear relationship between cerebrospinal fluid Aβ(42) and tau in preclinical Alzheimer’s disease
por: de Leon, Mony J., et al.
Publicado: (2018)

The golden ass : being the metamorphoses of Lucius Apuleius
Publicado: (1915)

The golden ass : being the metamorphoses of Lucius Apuleius
por: Lucius Apuleius
Publicado: (1965)

Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?
por: Paterson, Ross W., et al.
Publicado: (2015)

Effect of long-term storage in biobanks on cerebrospinal fluid biomarker Aβ(1-42), T-tau, and P-tau values
por: Willemse, Eline A.J., et al.
Publicado: (2017)

New screening approach for Alzheimer’s disease risk assessment from urine lipid peroxidation compounds
por: Peña-Bautista, Carmen, et al.
Publicado: (2019)

Each actor on his ass
por: Mac Liammóir, Micheál, 1899-1978
Publicado: (1961)

A Leadership Kick in the Ass
por: Treasurer, Bill
Publicado: (2017)

Feeding Infants with Asses’ Milk
Publicado: (1889)

Attempt to Infect the Ass with Tuberculin
Publicado: (1899)

Preoperative cerebrospinal fluid β-Amyloid/Tau ratio and postoperative delirium
por: Xie, Zhongcong, et al.
Publicado: (2014)

Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease
por: Jia, Longfei, et al.
Publicado: (2021)

Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels
por: Maxwell, Taylor J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ns7250gaolanc2tqvfrva237o5